When considering the combination panel of both genes (ADAMTS1 and/or BNC1), the combined panel was positive in 100% (8/8) of stage I, 88.9% (8/9) of stage IIA, 100% (20/20) of stage IIB, and 100% (2/2) of stages III and IV pancreatic cancers (Table 3). The gene discussed is ADAMTS1; the disease is familial pancreatic carcinoma.